APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pharma & Cosmetics

Pharma is a substance of the prevention or treatment for human diseases. It can be divided into natural medicine and synthetic medicine according to the source. Pharma is a material which can prevent and treat disease, reduce pain, improve health, or enhance the body's resistance to disease or to help diagnose diseases.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Pharma is a substance of the prevention or treatment for human diseases. It can be divided into natural medicine and synthetic medicine according to the source. Pharma is a material which can prevent and treat disease, reduce pain, improve health, or enhance the body's resistance to disease or to help diagnose diseases.

Selected research

Market Structure

Global Pharma & Cosmetics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 January 2026190 pages

Choose your research edition.

Industry ResearchPharma & Cosmetics Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharma & Cosmetics Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Pharma & Cosmetics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharma & Cosmetics Market Outlook and Growth Opportunities 2026200 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharma & Cosmetics Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

Pharma is a substance of the prevention or treatment for human diseases. It can be divided into natural medicine and synthetic medicine according to the source. Pharma is a material which can prevent and treat disease, reduce pain, improve health, or enhance the body's resistance to disease or to help diagnose diseases.

The major players in global Pharma & Cosmetics market include Johnson & Johnson, Roche, Novartis, etc., and the market concentration rate is low. China and Japan are main markets, they occupy about 40% of the global market. Pharmaceuticals, OTC is the main application, which holds a share about 75%.

This report provides an overview of the global Pharma & Cosmetics market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Pharma & Cosmetics and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pharma & Cosmetics sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pharma & Cosmetics market size, projected growth trends, production technologies, key applications, and end-use industries.

Pharma & Cosmetics Segment by Company

Johnson & Johnson

Roche

Novartis

Pfizer

Sanofi

Eli Lilly

GSK

Bayer

Merck & Co

L' OREAL

Unilever

Procter & Gamble

Estee Lauder

Kao

Shiseido

Beiersdorf

Henkel

Shanghai Jahwa

Pharma & Cosmetics Segment by Type

Ointments

Creams

Gels

Others

Pharma & Cosmetics Segment by Application

Pharmaceuticals, OTC

Cosmetics

Pharma & Cosmetics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharma & Cosmetics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharma & Cosmetics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharma & Cosmetics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pharma & Cosmetics market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pharma & Cosmetics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Pharma & Cosmetics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Pharma & Cosmetics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Pharma & Cosmetics Industry Trends Table 2. Pharma & Cosmetics Industry Drivers Table 3. Pharma & Cosmetics Industry Opportunities and Challenges Table 4. Pharma & Cosmetics Industry Restraints Table 5. Global Pharma & Cosmetics Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Pharma & Cosmetics Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Pharma & Cosmetics Sales by Manufacturers (kt) & (2021-2026) Table 8. Global Pharma & Cosmetics Sales Market Share by Manufacturers Table 9. Global Pharma & Cosmetics Average Sales Price (US$/t) of Manufacturers (2021-2026) Table 10. Global Pharma & Cosmetics Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Pharma & Cosmetics Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Pharma & Cosmetics Manufacturers, Product Type & Application Table 13. Global Pharma & Cosmetics Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Pharma & Cosmetics by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Ointments Table 17. Major Manufacturers of Creams Table 18. Major Manufacturers of Gels Table 19. Major Manufacturers of Others Table 20. Global Pharma & Cosmetics Sales by Type 2021 VS 2025 VS 2032 (kt) Table 21. Global Pharma & Cosmetics Sales by Type (2021-2026) & (kt) Table 22. Global Pharma & Cosmetics Sales by Type (2027-2032) & (kt) Table 23. Global Pharma & Cosmetics Sales Market Share by Type (2021-2026) Table 24. Global Pharma & Cosmetics Sales Market Share by Type (2027-2032) Table 25. Global Pharma & Cosmetics Revenue by Type 2021 VS 2025 VS 2032 (kt) Table 26. Global Pharma & Cosmetics Revenue by Type (2021-2026) & (kt) Table 27. Global Pharma & Cosmetics Revenue by Type (2027-2032) & (kt) Table 28. Global Pharma & Cosmetics Revenue Market Share by Type (2021-2026) Table 29. Global Pharma & Cosmetics Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Pharmaceuticals, OTC Table 31. Major Manufacturers of Cosmetics Table 32. Global Pharma & Cosmetics Sales by Application 2021 VS 2025 VS 2032 (kt) Table 33. Global Pharma & Cosmetics Sales by Application (2021-2026) & (kt) Table 34. Global Pharma & Cosmetics Sales by Application (2027-2032) & (kt) Table 35. Global Pharma & Cosmetics Sales Market Share by Application (2021-2026) Table 36. Global Pharma & Cosmetics Sales Market Share by Application (2027-2032) Table 37. Global Pharma & Cosmetics Revenue by Application 2021 VS 2025 VS 2032 (kt) Table 38. Global Pharma & Cosmetics Revenue by Application (2021-2026) & (kt) Table 39. Global Pharma & Cosmetics Revenue by Application (2027-2032) & (kt) Table 40. Global Pharma & Cosmetics Revenue Market Share by Application (2021-2026) Table 41. Global Pharma & Cosmetics Revenue Market Share by Application (2027-2032) Table 42. Global Pharma & Cosmetics Sales by Region: 2021 VS 2025 VS 2032 (kt) Table 43. Global Pharma & Cosmetics Sales by Region (2021-2026) & (kt) Table 44. Global Pharma & Cosmetics Sales Market Share by Region (2021-2026) Table 45. Global Pharma & Cosmetics Sales Forecasted by Region (2027-2032) & (kt) Table 46. Global Pharma & Cosmetics Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Pharma & Cosmetics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (kt) Table 48. North America Pharma & Cosmetics Sales by Country (2021-2026) & (kt) Table 49. North America Pharma & Cosmetics Sales by Country (2027-2032) & (kt) Table 50. Europe Pharma & Cosmetics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (kt) Table 51. Europe Pharma & Cosmetics Sales by Country (2021-2026) & (kt) Table 52. Europe Pharma & Cosmetics Sales by Country (2027-2032) & (kt) Table 53. Asia Pacific Pharma & Cosmetics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (kt) Table 54. Asia Pacific Pharma & Cosmetics Sales by Country (2021-2026) & (kt) Table 55. Asia Pacific Pharma & Cosmetics Sales by Country (2027-2032) & (kt) Table 56. South America, Middle East and Africa Pharma & Cosmetics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (kt) Table 57. South America, Middle East and Africa Pharma & Cosmetics Sales by Country (2021-2026) & (kt) Table 58. South America, Middle East and Africa Pharma & Cosmetics Sales by Country (2027-2032) & (kt) Table 59. Global Pharma & Cosmetics Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Pharma & Cosmetics Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Pharma & Cosmetics Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Pharma & Cosmetics Revenue Market Share by Region (2021-2026) Table 63. Global Pharma & Cosmetics Revenue Market Share by Region (2027-2032) Table 64. Johnson & Johnson Company Information Table 65. Johnson & Johnson Business Overview Table 66. Johnson & Johnson Pharma & Cosmetics Sales (kt), Price (US$/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Johnson & Johnson Pharma & Cosmetics Product Portfolio Table 68. Johnson & Johnson Recent Development Table 69. Roche Company Information Table 70. Roche Business Overview Table 71. Roche Pharma & Cosmetics Sales (kt), Price (US$/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Roche Pharma & Cosmetics Product Portfolio Table 73. Roche Recent Development Table 74. Novartis Company Information Table 75. Novartis Business Overview Table 76. Novartis Pharma & Cosmetics Sales (kt), Price (US$/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Novartis Pharma & Cosmetics Product Portfolio Table 78. Novartis Recent Development Table 79. Pfizer Company Information Table 80. Pfizer Business Overview Table 81. Pfizer Pharma & Cosmetics Sales (kt), Price (US$/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Pfizer Pharma & Cosmetics Product Portfolio Table 83. Pfizer Recent Development Table 84. Sanofi Company Information Table 85. Sanofi Business Overview Table 86. Sanofi Pharma & Cosmetics Sales (kt), Price (US$/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Sanofi Pharma & Cosmetics Product Portfolio Table 88. Sanofi Recent Development Table 89. Eli Lilly Company Information Table 90. Eli Lilly Business Overview Table 91. Eli Lilly Pharma & Cosmetics Sales (kt), Price (US$/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Eli Lilly Pharma & Cosmetics Product Portfolio Table 93. Eli Lilly Recent Development Table 94. GSK Company Information Table 95. GSK Business Overview Table 96. GSK Pharma & Cosmetics Sales (kt), Price (US$/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. GSK Pharma & Cosmetics Product Portfolio Table 98. GSK Recent Development Table 99. Bayer Company Information Table 100. Bayer Business Overview Table 101. Bayer Pharma & Cosmetics Sales (kt), Price (US$/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Bayer Pharma & Cosmetics Product Portfolio Table 103. Bayer Recent Development Table 104. Merck & Co Company Information Table 105. Merck & Co Business Overview Table 106. Merck & Co Pharma & Cosmetics Sales (kt), Price (US$/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Merck & Co Pharma & Cosmetics Product Portfolio Table 108. Merck & Co Recent Development Table 109. L' OREAL Company Information Table 110. L' OREAL Business Overview Table 111. L' OREAL Pharma & Cosmetics Sales (kt), Price (US$/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. L' OREAL Pharma & Cosmetics Product Portfolio Table 113. L' OREAL Recent Development Table 114. Unilever Company Information Table 115. Unilever Business Overview Table 116. Unilever Pharma & Cosmetics Sales (kt), Price (US$/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Unilever Pharma & Cosmetics Product Portfolio Table 118. Unilever Recent Development Table 119. Procter & Gamble Company Information Table 120. Procter & Gamble Business Overview Table 121. Procter & Gamble Pharma & Cosmetics Sales (kt), Price (US$/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Procter & Gamble Pharma & Cosmetics Product Portfolio Table 123. Procter & Gamble Recent Development Table 124. Estee Lauder Company Information Table 125. Estee Lauder Business Overview Table 126. Estee Lauder Pharma & Cosmetics Sales (kt), Price (US$/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. Estee Lauder Pharma & Cosmetics Product Portfolio Table 128. Estee Lauder Recent Development Table 129. Kao Company Information Table 130. Kao Business Overview Table 131. Kao Pharma & Cosmetics Sales (kt), Price (US$/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 132. Kao Pharma & Cosmetics Product Portfolio Table 133. Kao Recent Development Table 134. Shiseido Company Information Table 135. Shiseido Business Overview Table 136. Shiseido Pharma & Cosmetics Sales (kt), Price (US$/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 137. Shiseido Pharma & Cosmetics Product Portfolio Table 138. Shiseido Recent Development Table 139. Beiersdorf Company Information Table 140. Beiersdorf Business Overview Table 141. Beiersdorf Pharma & Cosmetics Sales (kt), Price (US$/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 142. Beiersdorf Pharma & Cosmetics Product Portfolio Table 143. Beiersdorf Recent Development Table 144. Henkel Company Information Table 145. Henkel Business Overview Table 146. Henkel Pharma & Cosmetics Sales (kt), Price (US$/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 147. Henkel Pharma & Cosmetics Product Portfolio Table 148. Henkel Recent Development Table 149. Shanghai Jahwa Company Information Table 150. Shanghai Jahwa Business Overview Table 151. Shanghai Jahwa Pharma & Cosmetics Sales (kt), Price (US$/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 152. Shanghai Jahwa Pharma & Cosmetics Product Portfolio Table 153. Shanghai Jahwa Recent Development Table 154. Key Raw Materials Table 155. Raw Materials Key Suppliers Table 156. Pharma & Cosmetics Distributors List Table 157. Pharma & Cosmetics Customers List Table 158. Research Programs/Design for This Report Table 159. Authors List of This Report Table 160. Secondary Sources Table 161. Primary Sources List of Figures Figure 1. Pharma & Cosmetics Product Image Figure 2. Global Pharma & Cosmetics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pharma & Cosmetics Market Size (2021-2032) & (US$ Million) Figure 4. Global Pharma & Cosmetics Sales (2021-2032) & (kt) Figure 5. Global Pharma & Cosmetics Average Price (US$/t) & (2021-2032) Figure 6. Global Top 5 and 10 Pharma & Cosmetics Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Ointments Image Figure 9. Creams Image Figure 10. Gels Image Figure 11. Others Image Figure 12. Global Pharma & Cosmetics Sales by Type (2021 VS 2025 VS 2032) & (kt) Figure 13. Global Pharma & Cosmetics Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Pharma & Cosmetics Sales Market Share by Type (2021-2032) Figure 15. Global Pharma & Cosmetics Revenue by Type (2021 VS 2025 VS 2032) & (kt) Figure 16. Global Pharma & Cosmetics Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Pharma & Cosmetics Revenue Market Share by Type (2021-2032) Figure 18. Pharmaceuticals, OTC Image Figure 19. Cosmetics Image Figure 20. Global Pharma & Cosmetics Sales by Application (2021 VS 2025 VS 2032) & (kt) Figure 21. Global Pharma & Cosmetics Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Pharma & Cosmetics Sales Market Share by Application (2021-2032) Figure 23. Global Pharma & Cosmetics Revenue by Application (2021 VS 2025 VS 2032) & (kt) Figure 24. Global Pharma & Cosmetics Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Pharma & Cosmetics Revenue Market Share by Application (2021-2032) Figure 26. North America Pharma & Cosmetics Sales and Growth Rate (2021-2032) & (kt) Figure 27. North America Pharma & Cosmetics Sales Market Share by Country (2021-2032) Figure 28. U.S. Pharma & Cosmetics Sales and Growth Rate (2021-2032) & (kt) Figure 29. Canada Pharma & Cosmetics Sales and Growth Rate (2021-2032) & (kt) Figure 30. Mexico Pharma & Cosmetics Sales and Growth Rate (2021-2032) & (kt) Figure 31. Europe Pharma & Cosmetics Sales and Growth Rate (2021-2032) & (kt) Figure 32. Europe Pharma & Cosmetics Sales Market Share by Country (2021-2032) Figure 33. Germany Pharma & Cosmetics Sales and Growth Rate (2021-2032) & (kt) Figure 34. France Pharma & Cosmetics Sales and Growth Rate (2021-2032) & (kt) Figure 35. U.K. Pharma & Cosmetics Sales and Growth Rate (2021-2032) & (kt) Figure 36. Italy Pharma & Cosmetics Sales and Growth Rate (2021-2032) & (kt) Figure 37. Netherlands Pharma & Cosmetics Sales and Growth Rate (2021-2032) & (kt) Figure 38. Asia Pacific Pharma & Cosmetics Sales and Growth Rate (2021-2032) & (kt) Figure 39. Asia Pacific Pharma & Cosmetics Sales Market Share by Country (2021-2032) Figure 40. China Pharma & Cosmetics Sales and Growth Rate (2021-2032) & (kt) Figure 41. Japan Pharma & Cosmetics Sales and Growth Rate (2021-2032) & (kt) Figure 42. South Korea Pharma & Cosmetics Sales and Growth Rate (2021-2032) & (kt) Figure 43. Southeast Asia Pharma & Cosmetics Sales and Growth Rate (2021-2032) & (kt) Figure 44. India Pharma & Cosmetics Sales and Growth Rate (2021-2032) & (kt) Figure 45. Australia Pharma & Cosmetics Sales and Growth Rate (2021-2032) & (kt) Figure 46. South America, Middle East and Africa Pharma & Cosmetics Sales and Growth Rate (2021-2032) & (kt) Figure 47. South America, Middle East and Africa Pharma & Cosmetics Sales Market Share by Country (2021-2032) Figure 48. Brazil Pharma & Cosmetics Sales and Growth Rate (2021-2032) & (kt) Figure 49. South Africa Pharma & Cosmetics Sales and Growth Rate (2021-2032) & (kt) Figure 50. Saudi Arabia Pharma & Cosmetics Sales and Growth Rate (2021-2032) & (kt) Figure 51. Turkey Pharma & Cosmetics Sales and Growth Rate (2021-2032) & (kt) Figure 52. Argentina Pharma & Cosmetics Sales and Growth Rate (2021-2032) & (kt) Figure 53. UAE Pharma & Cosmetics Sales and Growth Rate (2021-2032) & (kt) Figure 54. Egypt Pharma & Cosmetics Sales and Growth Rate (2021-2032) & (kt) Figure 55. Chile Pharma & Cosmetics Sales and Growth Rate (2021-2032) & (kt) Figure 56. Global Pharma & Cosmetics Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Pharma & Cosmetics Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Pharma & Cosmetics Revenue (2021-2032) & (US$ Million) Figure 59. North America Pharma & Cosmetics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Pharma & Cosmetics Revenue (2021-2032) & (US$ Million) Figure 61. Europe Pharma & Cosmetics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Pharma & Cosmetics Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Pharma & Cosmetics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Pharma & Cosmetics Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Pharma & Cosmetics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Pharma & Cosmetics Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Pharma & Cosmetics Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Ointments
  • Creams
  • Gels
  • Others
Applications
  • Pharmaceuticals, OTC
  • Cosmetics
Companies covered
  • Johnson & Johnson
  • Roche
  • Novartis
  • Pfizer
  • Sanofi
  • Eli Lilly
  • GSK
  • Bayer
  • Merck & Co
  • L' OREAL
  • Unilever
  • Procter & Gamble
  • Estee Lauder
  • Kao
  • Shiseido
  • Beiersdorf
  • Henkel
  • Shanghai Jahwa

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pharma & Cosmetics Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pharma & Cosmetics Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Pharma & Cosmetics Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Pharma & Cosmetics Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Pharma & Cosmetics Market Dynamics
  1. 2.1 Pharma & Cosmetics Industry Trends
  2. 2.2 Pharma & Cosmetics Industry Drivers
  3. 2.3 Pharma & Cosmetics Industry Opportunities and Challenges
  4. 2.4 Pharma & Cosmetics Industry Restraints
3 Pharma & Cosmetics Market by Manufacturers
  1. 3.1 Global Pharma & Cosmetics Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Pharma & Cosmetics Sales by Manufacturers (2021-2026)
  3. 3.3 Global Pharma & Cosmetics Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Pharma & Cosmetics Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pharma & Cosmetics Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Pharma & Cosmetics Manufacturers, Product Type & Application
  7. 3.7 Global Pharma & Cosmetics Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pharma & Cosmetics Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pharma & Cosmetics Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Pharma & Cosmetics Tier 1, Tier 2, and Tier 3
4 Pharma & Cosmetics Market by Type
  1. 4.1 Pharma & Cosmetics Type Introduction
  2. 4.1.1 Ointments
  3. 4.1.2 Creams
  4. 4.1.3 Gels
  5. 4.1.4 Others
  6. 4.2 Global Pharma & Cosmetics Sales by Type
  7. 4.2.1 Global Pharma & Cosmetics Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Pharma & Cosmetics Sales by Type (2021-2032)
  9. 4.2.3 Global Pharma & Cosmetics Sales Market Share by Type (2021-2032)
  10. 4.3 Global Pharma & Cosmetics Revenue by Type
  11. 4.3.1 Global Pharma & Cosmetics Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Pharma & Cosmetics Revenue by Type (2021-2032)
  13. 4.3.3 Global Pharma & Cosmetics Revenue Market Share by Type (2021-2032)
5 Pharma & Cosmetics Market by Application
  1. 5.1 Pharma & Cosmetics Application Introduction
  2. 5.1.1 Pharmaceuticals, OTC
  3. 5.1.2 Cosmetics
  4. 5.2 Global Pharma & Cosmetics Sales by Application
  5. 5.2.1 Global Pharma & Cosmetics Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Pharma & Cosmetics Sales by Application (2021-2032)
  7. 5.2.3 Global Pharma & Cosmetics Sales Market Share by Application (2021-2032)
  8. 5.3 Global Pharma & Cosmetics Revenue by Application
  9. 5.3.1 Global Pharma & Cosmetics Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Pharma & Cosmetics Revenue by Application (2021-2032)
  11. 5.3.3 Global Pharma & Cosmetics Revenue Market Share by Application (2021-2032)
6 Global Pharma & Cosmetics Sales by Region
  1. 6.1 Global Pharma & Cosmetics Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pharma & Cosmetics Sales by Region (2021-2032)
  3. 6.2.1 Global Pharma & Cosmetics Sales by Region (2021-2026)
  4. 6.2.2 Global Pharma & Cosmetics Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pharma & Cosmetics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Pharma & Cosmetics Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Pharma & Cosmetics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Pharma & Cosmetics Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Pharma & Cosmetics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Pharma & Cosmetics Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Pharma & Cosmetics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Pharma & Cosmetics Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Pharma & Cosmetics Revenue by Region
  1. 7.1 Global Pharma & Cosmetics Revenue by Region
  2. 7.1.1 Global Pharma & Cosmetics Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Pharma & Cosmetics Revenue by Region (2021-2026)
  4. 7.1.3 Global Pharma & Cosmetics Revenue by Region (2027-2032)
  5. 7.1.4 Global Pharma & Cosmetics Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Pharma & Cosmetics Revenue (2021-2032)
  8. 7.2.2 North America Pharma & Cosmetics Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Pharma & Cosmetics Revenue (2021-2032)
  11. 7.3.2 Europe Pharma & Cosmetics Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Pharma & Cosmetics Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Pharma & Cosmetics Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Pharma & Cosmetics Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Pharma & Cosmetics Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Johnson & Johnson
  2. 8.1.1 Johnson & Johnson Company Information
  3. 8.1.2 Johnson & Johnson Business Overview
  4. 8.1.3 Johnson & Johnson Pharma & Cosmetics Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Johnson & Johnson Pharma & Cosmetics Product Portfolio
  6. 8.1.5 Johnson & Johnson Recent Developments
  7. 8.2 Roche
  8. 8.2.1 Roche Company Information
  9. 8.2.2 Roche Business Overview
  10. 8.2.3 Roche Pharma & Cosmetics Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Roche Pharma & Cosmetics Product Portfolio
  12. 8.2.5 Roche Recent Developments
  13. 8.3 Novartis
  14. 8.3.1 Novartis Company Information
  15. 8.3.2 Novartis Business Overview
  16. 8.3.3 Novartis Pharma & Cosmetics Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Novartis Pharma & Cosmetics Product Portfolio
  18. 8.3.5 Novartis Recent Developments
  19. 8.4 Pfizer
  20. 8.4.1 Pfizer Company Information
  21. 8.4.2 Pfizer Business Overview
  22. 8.4.3 Pfizer Pharma & Cosmetics Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Pfizer Pharma & Cosmetics Product Portfolio
  24. 8.4.5 Pfizer Recent Developments
  25. 8.5 Sanofi
  26. 8.5.1 Sanofi Company Information
  27. 8.5.2 Sanofi Business Overview
  28. 8.5.3 Sanofi Pharma & Cosmetics Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Sanofi Pharma & Cosmetics Product Portfolio
  30. 8.5.5 Sanofi Recent Developments
  31. 8.6 Eli Lilly
  32. 8.6.1 Eli Lilly Company Information
  33. 8.6.2 Eli Lilly Business Overview
  34. 8.6.3 Eli Lilly Pharma & Cosmetics Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Eli Lilly Pharma & Cosmetics Product Portfolio
  36. 8.6.5 Eli Lilly Recent Developments
  37. 8.7 GSK
  38. 8.7.1 GSK Company Information
  39. 8.7.2 GSK Business Overview
  40. 8.7.3 GSK Pharma & Cosmetics Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 GSK Pharma & Cosmetics Product Portfolio
  42. 8.7.5 GSK Recent Developments
  43. 8.8 Bayer
  44. 8.8.1 Bayer Company Information
  45. 8.8.2 Bayer Business Overview
  46. 8.8.3 Bayer Pharma & Cosmetics Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Bayer Pharma & Cosmetics Product Portfolio
  48. 8.8.5 Bayer Recent Developments
  49. 8.9 Merck & Co
  50. 8.9.1 Merck & Co Company Information
  51. 8.9.2 Merck & Co Business Overview
  52. 8.9.3 Merck & Co Pharma & Cosmetics Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Merck & Co Pharma & Cosmetics Product Portfolio
  54. 8.9.5 Merck & Co Recent Developments
  55. 8.10 L' OREAL
  56. 8.10.1 L' OREAL Company Information
  57. 8.10.2 L' OREAL Business Overview
  58. 8.10.3 L' OREAL Pharma & Cosmetics Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 L' OREAL Pharma & Cosmetics Product Portfolio
  60. 8.10.5 L' OREAL Recent Developments
  61. 8.11 Unilever
  62. 8.11.1 Unilever Company Information
  63. 8.11.2 Unilever Business Overview
  64. 8.11.3 Unilever Pharma & Cosmetics Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Unilever Pharma & Cosmetics Product Portfolio
  66. 8.11.5 Unilever Recent Developments
  67. 8.12 Procter & Gamble
  68. 8.12.1 Procter & Gamble Company Information
  69. 8.12.2 Procter & Gamble Business Overview
  70. 8.12.3 Procter & Gamble Pharma & Cosmetics Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Procter & Gamble Pharma & Cosmetics Product Portfolio
  72. 8.12.5 Procter & Gamble Recent Developments
  73. 8.13 Estee Lauder
  74. 8.13.1 Estee Lauder Company Information
  75. 8.13.2 Estee Lauder Business Overview
  76. 8.13.3 Estee Lauder Pharma & Cosmetics Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Estee Lauder Pharma & Cosmetics Product Portfolio
  78. 8.13.5 Estee Lauder Recent Developments
  79. 8.14 Kao
  80. 8.14.1 Kao Company Information
  81. 8.14.2 Kao Business Overview
  82. 8.14.3 Kao Pharma & Cosmetics Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Kao Pharma & Cosmetics Product Portfolio
  84. 8.14.5 Kao Recent Developments
  85. 8.15 Shiseido
  86. 8.15.1 Shiseido Company Information
  87. 8.15.2 Shiseido Business Overview
  88. 8.15.3 Shiseido Pharma & Cosmetics Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Shiseido Pharma & Cosmetics Product Portfolio
  90. 8.15.5 Shiseido Recent Developments
  91. 8.16 Beiersdorf
  92. 8.16.1 Beiersdorf Company Information
  93. 8.16.2 Beiersdorf Business Overview
  94. 8.16.3 Beiersdorf Pharma & Cosmetics Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Beiersdorf Pharma & Cosmetics Product Portfolio
  96. 8.16.5 Beiersdorf Recent Developments
  97. 8.17 Henkel
  98. 8.17.1 Henkel Company Information
  99. 8.17.2 Henkel Business Overview
  100. 8.17.3 Henkel Pharma & Cosmetics Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Henkel Pharma & Cosmetics Product Portfolio
  102. 8.17.5 Henkel Recent Developments
  103. 8.18 Shanghai Jahwa
  104. 8.18.1 Shanghai Jahwa Company Information
  105. 8.18.2 Shanghai Jahwa Business Overview
  106. 8.18.3 Shanghai Jahwa Pharma & Cosmetics Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Shanghai Jahwa Pharma & Cosmetics Product Portfolio
  108. 8.18.5 Shanghai Jahwa Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Pharma & Cosmetics Value Chain Analysis
  2. 9.1.1 Pharma & Cosmetics Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Pharma & Cosmetics Production Mode & Process
  6. 9.2 Pharma & Cosmetics Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Pharma & Cosmetics Distributors
  9. 9.2.3 Pharma & Cosmetics Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst